Maxlinear (MXL) Research & Development (2010 - 2026)

Maxlinear (MXL) has reported Research & Development for 17 consecutive years, with $56.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Research & Development rose 18.72% year-over-year to $56.0 million; the TTM figure through Jun 2026 stood at $215.1 million (up 4.16% YoY), while the FY2025 annual figure was $208.6 million, down 7.37% from the prior year.
• Research & Development advanced to $56.0 million in Q2 2026 per MXL's latest filing, from $53.2 million in the prior quarter.
• Across five years, Research & Development topped out at $80.4 million in Q2 2022 and bottomed at $47.2 million in Q2 2025.
• Historically, Research & Development has averaged $61.6 million across 5 years, with a median of $60.7 million in 2024.
• Annual changes were most pronounced in 2024 — Research & Development declined 21.41% — and 2026, when it rose 18.72%.
• Maxlinear's Research & Development stood at $73.7 million in 2022, then dropped by 11.49% to $65.2 million in 2023, then slipped by 21.41% to $51.3 million in 2024, then climbed by 0.81% to $51.7 million in 2025, then gained by 8.4% to $56.0 million in 2026.
• Business Quant data shows MXL's Research & Development at $56.0 million in Q2 2026, $53.2 million in Q1 2026, and $51.7 million in Q4 2025.